| GILEAD SCIENCES DL-,001 |
| USA |
| Gesundheit |
| US3755581036 / 885823 |
| GIS (Frankfurt) / GILD (NASDAQ) |
| FRA:GIS, ETR:GIS, GIS:GR, NASDAQ:GILD |
| https://www.gilead.com/ |
|
Gilead Sciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious diseases with unmet medical needs. Gilead Sciences specializes in therapeutic areas including HIV, viral hepatitis, onc..
>Volltext.. |
| 162059.74 Mio. EUR |
| 180678.86 Mio. EUR |
| 26594.11 Mio. EUR |
| 12770.29 Mio. EUR |
| -2821.01 Mio. EUR |
| -2.27 EUR |
| 22851.92 Mio. EUR |
| 2767.9 Mio. EUR |
| 11799.48 Mio. EUR |
| 0.44 |
| 9.39% |
| -152.95% |
| 2.8 EUR |
| 2.13% |
| 2.18% |
| 15.09.26 - 0.710366€ 15.06.26 - 0.707578€ >weitere anzeigen... |
| 5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 5.658.043 Euro. |
| GILEAD, REMDESIVIR |
| 20.09.26 |
|